A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)
Clinical trial NCT03894280 · COMPLETED
Trial details
- NCT number
- NCT03894280
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2019-04-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.